Next Day Disclosure Returns - [Share Buyback]

HBM Holdings Limited operates as a biopharmaceutical company. The Company develops novel and highly differentiated antibody therapeutics in immunology and oncology disease areas. HBM Holdings provides its services throughout China.

Next Day Disclosure Return

Announcements and Notices - [Other - Business Update]

Voluntary Announcement - Submission Of Investigational New Drug Application For
Hbm9378/Skb378 (Anti-Tslp) For Copd To The National Medical
Products Administration Of China

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Next Day Disclosure Return

Voluntary Announcement - Submission Of Investigational New Drug Application For Hbm9378/Skb378 (Anti-Tslp) For Copd To The National Medical Products Administration Of China